Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Optimized Pacing Eases oHCM Symptoms in EMORI-HCM Trial
Added: 4 months ago Source:  Radcliffe Cardiology
For patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), the net effect of right ventricular pacing (RVP) has been variable. A new trial suggests that personalising the therapy by electromechanically optimising the atrio-ventricular delay (AVD) can provide a net benefit for symptoms and exercise capacity.¹Right ventricular pacing can reduce the left ventricular outflow tract… View more

Electrophysiology & Arrhythmia

Heart Failure
Jose Luis Navia
Research Area(s) / Expertise: Job title: Director of Heart and Vascular Center
Dr Jose L Navia is the Director of the Heart and Vascular Center at Cleveland Clinic Florida; Chairman of Cardiothoracic Surgery in Florida; and the S. Donald Sussman Distinguished Chair in Heart and Vascular Research. Dr Navia is also Professor of Surgery at Cleveland Clinic Lerner College of Medicine. Dr Navia earned his medical degree from the School of Medicine at the National University of… View more
Zaza Iakobishvili
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

Prevention & Chronic Conditions

 Job title: Director
Since January 2018, Zaza Iakobishvili, MD, PhD, has served as the department's director in the Tel Aviv-Jaffa district of Clalit Health Services, the country's largest provider of healthcare services. He is actively engaged in the organisation of community heart failure and cardio-oncology trials in Israel. In 2013, Dr. Iakobishvili opened the first cardio-oncology specialty clinic in Israel… View more
Optimized Pacing Eases oHCM Symptoms in EMORI-HCM Trial
Added: 5 months ago Source:  Radcliffe Cardiology
For patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), the net effect of right ventricular pacing (RVP) has been variable, as it can reduce the left ventricular outflow tract gradient (LVOTg) but may also decrease cardiac output.¹ The EMORI-HCM trial investigated whether electromechanically optimising the atrio-ventricular delay (AVD) could allow RVP to achieve a consistent… View more

Electrophysiology & Arrhythmia

Heart Failure
A Pieter Kappetein
Job title: Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program
Dr. Pieter Kappetein, MD, PhD, is a Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program at the Thoraxcenter at the Erasmus Medical Centre in Rotterdam, The Netherlands. He is board certified in Cardiothoracic Surgery. His specialty is cardiothoracic surgery. He is Secretary General of the European Association for Cardio-thoracic Surgery, President of CTSnet and member… View more
Arrhythmias and Sudden Death: What is New in HCM?
Author(s): Deepthi Rajan , Christopher Ryan Zörner , Morten Lock Hansen , et al Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
ACC 25: The MyPEAK-1 Study
Author(s): Milind Y Desai Added: 1 year ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene… View more

Heart Failure
CMR Phenotyping More Accurately Predicts Arrhythmic Risk in Cardiac Sarcoidosis
Added: 9 months ago Source:  Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has… View more

Imaging & Diagnostics

Electrophysiology & Arrhythmia
Dr Duncan Hogg, gained his medical qualification at the University of Aberdeen in 1994. In 1997 he became a Member of the Royal College of Physicians. Dr Hogg received his general cardiology training at Aberdeen Royal Infirmary and completed specialist training in Cardiology & General Internal Medicine (GIM) in 2007. Dr Hogg has Specialist Registration with the General Medical Council for… View more
Job title: Associate Director of Medical and Scientific Affairs